Literature DB >> 23072816

MicroRNA-10A* and MicroRNA-21 modulate endothelial progenitor cell senescence via suppressing high-mobility group A2.

Shoukang Zhu1, Shanming Deng, Qi Ma, Taifang Zhang, Chunling Jia, Degen Zhuo, Falin Yang, Jianqin Wei, Liyong Wang, Derek M Dykxhoorn, Joshua M Hare, Pascal J Goldschmidt-Clermont, Chunming Dong.   

Abstract

RATIONALE: Endothelial progenitor cells (EPCs) contribute to the regeneration of endothelium. Aging-associated senescence results in reduced number and function of EPCs, potentially contributing to increased cardiac risk, reduced angiogenic capacity, and impaired cardiac repair effectiveness. The mechanisms underlying EPC senescence are unknown. Increasing evidence supports the role of microRNAs in regulating cellular senescence.
OBJECTIVE: We aimed to determine whether microRNAs regulated EPC senescence and, if so, what the underlying mechanisms are. METHODS AND
RESULTS: To map the microRNA/gene expression signatures of EPC senescence, we performed microRNA profiling and microarray analysis in lineage-negative bone marrow cells from young and aged wild-type and apolipoprotein E-deficient mice. We identified 2 microRNAs, microRNA-10A* (miR-10A*), and miR-21, and their common target gene Hmga2 as critical regulators for EPC senescence. Overexpression of miR-10A* and miR-21 in young EPCs suppressed Hmga2 expression, caused EPC senescence, as evidenced by senescence-associated β-galactosidase upregulation, decreased self-renewal potential, increased p16(Ink4a)/p19(Arf) expression, and resulted in impaired EPC angiogenesis in vitro and in vivo, resembling EPCs derived from aged mice. In contrast, suppression of miR-10A* and miR-21 in aged EPCs increased Hmga2 expression, rejuvenated EPCs, resulting in decreased senescence-associated β-galactosidase expression, increased self-renewal potential, decreased p16(Ink4a)/p19(Arf) expression, and improved EPC angiogenesis in vitro and in vivo. Importantly, these phenotypic changes were rescued by miRNA-resistant Hmga2 cDNA overexpression.
CONCLUSIONS: miR-10A* and miR-21 regulate EPC senescence via suppressing Hmga2 expression and modulation of microRNAs may represent a potential therapeutic intervention in improving EPC-mediated angiogenesis and vascular repair.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23072816      PMCID: PMC3719009          DOI: 10.1161/CIRCRESAHA.112.280016

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  33 in total

Review 1.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

2.  High-level expression of DNA architectural factor HMGA2 and its association with nucleosomes in human embryonic stem cells.

Authors:  Ou Li; Dileep Vasudevan; Curt A Davey; Peter Dröge
Journal:  Genesis       Date:  2006-11       Impact factor: 2.487

3.  Aging in the atherosclerosis milieu may accelerate the consumption of bone marrow endothelial progenitor cells.

Authors:  Shoukang Zhu; Xialin Liu; Ying Li; Pascal J Goldschmidt-Clermont; Chunming Dong
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-11-09       Impact factor: 8.311

4.  Impaired progenitor cell activity in age-related endothelial dysfunction.

Authors:  Christian Heiss; Stefanie Keymel; Ulrike Niesler; Jutta Ziemann; Malte Kelm; Christoph Kalka
Journal:  J Am Coll Cardiol       Date:  2005-05-03       Impact factor: 24.094

5.  Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting.

Authors:  Robert J Scheubel; Holger Zorn; Rolf-Edgar Silber; Oliver Kuss; Henning Morawietz; Juergen Holtz; Andreas Simm
Journal:  J Am Coll Cardiol       Date:  2003-12-17       Impact factor: 24.094

Review 6.  Molecular biology of HMGA proteins: hubs of nuclear function.

Authors:  R Reeves
Journal:  Gene       Date:  2001-10-17       Impact factor: 3.688

7.  Aging, progenitor cell exhaustion, and atherosclerosis.

Authors:  Frederick M Rauscher; Pascal J Goldschmidt-Clermont; Bryce H Davis; Tao Wang; David Gregg; Priya Ramaswami; Anne M Pippen; Brian H Annex; Chunming Dong; Doris A Taylor
Journal:  Circulation       Date:  2003-07-14       Impact factor: 29.690

Review 8.  Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all.

Authors:  Jesús Gil; Gordon Peters
Journal:  Nat Rev Mol Cell Biol       Date:  2006-09       Impact factor: 94.444

9.  Overexpression of angiopoietin-1 increases CD133+/c-kit+ cells and reduces myocardial apoptosis in db/db mouse infarcted hearts.

Authors:  Heng Zeng; Lanfang Li; Jian-Xiong Chen
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

10.  RNAhybrid: microRNA target prediction easy, fast and flexible.

Authors:  Jan Krüger; Marc Rehmsmeier
Journal:  Nucleic Acids Res       Date:  2006-07-01       Impact factor: 16.971

View more
  55 in total

Review 1.  Developing miRNA therapeutics for cardiac repair in ischemic heart disease.

Authors:  Kai Zhu; Dingqian Liu; Hao Lai; Jun Li; Chunsheng Wang
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

Review 2.  miR-21 in ischemia/reperfusion injury: a double-edged sword?

Authors:  Xialian Xu; Alison J Kriegel; Xiaoyan Jiao; Hong Liu; Xiaowen Bai; Jessica Olson; Mingyu Liang; Xiaoqiang Ding
Journal:  Physiol Genomics       Date:  2014-08-26       Impact factor: 3.107

Review 3.  MicroRNAs, immune cells and pregnancy.

Authors:  Mallikarjun Bidarimath; Kasra Khalaj; Jocelyn M Wessels; Chandrakant Tayade
Journal:  Cell Mol Immunol       Date:  2014-06-23       Impact factor: 11.530

4.  MiR-21 suppresses endothelial progenitor cell proliferation by activating the TGFβ signaling pathway via downregulation of WWP1.

Authors:  Keqiang Zuo; Maoquan Li; Xiaoping Zhang; Chenghui Lu; Shi Wang; Kangkang Zhi; Bin He
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

5.  MiR-185 acts as a tumor suppressor by targeting AKT1 in non-small cell lung cancer cells.

Authors:  Shuai Li; Yulian Ma; Xinfang Hou; Ying Liu; Ke Li; Shuning Xu; Jufeng Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

6.  Therapeutic Potential of Modulating microRNAs in Atherosclerotic Vascular Disease.

Authors:  Elisa Araldi; Aranzazu Chamorro-Jorganes; Coe van Solingen; C Fernández-Hernando; Y Suárez
Journal:  Curr Vasc Pharmacol       Date:  2013-05-13       Impact factor: 2.719

Review 7.  Extracellular Vesicles and Vascular Injury: New Insights for Radiation Exposure.

Authors:  Stéphane Flamant; Radia Tamarat
Journal:  Radiat Res       Date:  2016-07-26       Impact factor: 2.841

Review 8.  Regulation of SIRT1 by oxidative stress-responsive miRNAs and a systematic approach to identify its role in the endothelium.

Authors:  Zhen Chen; Tzu-Pin Shentu; Liang Wen; David A Johnson; John Y-J Shyy
Journal:  Antioxid Redox Signal       Date:  2013-04-25       Impact factor: 8.401

Review 9.  HMGA2 and high-grade serous ovarian carcinoma.

Authors:  Jingjing Wu; Jian-Jun Wei
Journal:  J Mol Med (Berl)       Date:  2013-05-19       Impact factor: 4.599

Review 10.  MicroRNAs as pharmacological targets in endothelial cell function and dysfunction.

Authors:  Aránzazu Chamorro-Jorganes; Elisa Araldi; Yajaira Suárez
Journal:  Pharmacol Res       Date:  2013-04-18       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.